Bridgewater Associates LP reduced its position in UFP Technologies, Inc. (NASDAQ:UFPT – Free Report) by 43.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,388 shares of the industrial products company’s stock after selling 2,587 shares during the period. Bridgewater Associates LP’s holdings in UFP Technologies were worth $1,073,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of the company. Northwest Investment Counselors LLC bought a new stake in shares of UFP Technologies during the 3rd quarter worth about $32,000. EverSource Wealth Advisors LLC boosted its stake in UFP Technologies by 1,614.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 120 shares of the industrial products company’s stock valued at $30,000 after purchasing an additional 113 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in UFP Technologies during the 2nd quarter valued at approximately $36,000. GAMMA Investing LLC boosted its stake in UFP Technologies by 77.9% during the 3rd quarter. GAMMA Investing LLC now owns 137 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 60 shares during the period. Finally, Truvestments Capital LLC bought a new stake in UFP Technologies during the 3rd quarter valued at approximately $56,000. 87.28% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at UFP Technologies
In other UFP Technologies news, VP Jason Holt sold 146 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $342.69, for a total value of $50,032.74. Following the completion of the transaction, the vice president now owns 6,721 shares of the company’s stock, valued at $2,303,219.49. This represents a 2.13 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO R Jeffrey Bailly sold 12,533 shares of the stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $346.46, for a total value of $4,342,183.18. Following the completion of the transaction, the chief executive officer now directly owns 31,194 shares of the company’s stock, valued at approximately $10,807,473.24. The trade was a 28.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,326 shares of company stock valued at $4,620,154 in the last quarter. Corporate insiders own 6.17% of the company’s stock.
UFP Technologies Price Performance
UFP Technologies Company Profile
UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.
Featured Stories
- Five stocks we like better than UFP Technologies
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What Makes a Stock a Good Dividend Stock?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- How to Calculate Return on Investment (ROI)
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for UFP Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UFP Technologies and related companies with MarketBeat.com's FREE daily email newsletter.